Novo Nordisk A/S (NVO) — the earnings record

As of the 2026-11-03 card — updated after each print. An investment research diary, not advice.

The record at a glance

Reactions across the covered prints span -5.3% to +9.9% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries Reported 4 November before the open: EPS $0.89 vs $0.73, revenue ~$11.86B vs ~$11.08B (vendor, per US share) — a beat on both lines; 2026 outlook raised to adjusted sales growth of −2% to +2% at constant exchange rates. Window from Wednesday’s close of 42.18: paid ≥ 43.45, sold < 40.91, scored Monday 9 November: flat, −1.9%. Next print est 3 February 2027 (vendor). into the next print.

Print by print

The per-print reaction chart, the load-bearing metric and the behavior read live on the full NVO print-record card — free registration.